HUCOG 5000 HP Injection contains Human Chorionic Gonadotropin (hCG) at a concentration of 5000 IU per vial. hCG is a glycoprotein hormone produced during pregnancy, structurally similar to luteinizing hormone (LH), and is utilized therapeutically to stimulate ovulation and support reproductive function. HUCOG 5000 HP is indicated for the treatment of infertility in both males and females. In females, it is used to induce ovulation and support the luteal phase in assisted reproductive technologies such as in vitro fertilization (IVF). In males, it stimulates Leydig cells in the testes to produce testosterone, thereby aiding in the treatment of hypogonadism and promoting spermatogenesis. The injection is administered intramuscularly or subcutaneously as per physician guidance. Dosage and duration depend on the specific clinical condition and patient response. HUCOG 5000 HP should be used under strict medical supervision due to potential side effects including ovarian hyperstimulation syndrome (OHSS), allergic reactions, and local injection site reactions. It is contraindicated in patients with hormone-sensitive tumors or hypersensitivity to hCG. Proper storage conditions must be maintained to preserve potency. This preparation offers a reliable option for managing reproductive endocrine disorders and enhancing fertility outcomes.